UROGENITAL CANCER
Clinical trials for UROGENITAL CANCER explained in plain language.
Never miss a new study
Get alerted when new UROGENITAL CANCER trials appear
Sign up with your email to follow new studies for UROGENITAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immune-boosting drug may shrink tumors before bladder cancer surgery
Disease control Recruiting nowThis study tests whether giving the drug atezolizumab before surgery can shrink tumors in people with certain types of urinary tract cancer. Atezolizumab helps the immune system recognize and attack cancer cells. About 58 adults will receive two cycles of the drug, then undergo s…
Matched conditions: UROGENITAL CANCER
Phase: PHASE2 • Sponsor: Queen Mary University of London • Aim: Disease control
Last updated May 15, 2026 12:07 UTC
-
New drug combo aims to boost immune system against Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase study tests two drugs, bintrafusp alfa and PDS01ADC, alone or with targeted radiation, in adults with metastatic bladder, kidney, or other non-prostate genitourinary cancers. The goal is to see if the combination helps the immune system fight cancer better. About…
Matched conditions: UROGENITAL CANCER
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 11, 2026 20:48 UTC
-
Massive study tracks rare urinary cancers to unlock treatment secrets
Knowledge-focused Recruiting nowThis study follows 1,100 adults with common and rare urinary tract cancers (like bladder, kidney, or testicular cancer) over their lifetime. Researchers collect medical records, blood, urine, and tumor samples to understand how these cancers behave and respond to treatments. The …
Matched conditions: UROGENITAL CANCER
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 07, 2026 18:42 UTC